aDepartment of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC;
bDepartment of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston MA;
cMetabolism Unit, Harvard Medical School, Massachusetts General Hospital, Boston, MA
dDivision of Infectious Diseases, University of Cincinnati, Cincinnati, OH;
eSocial and Scientific Systems, a DLH Company, Silver Spring, MD
fDepartment of Medicine, University of Texas Southwestern, Dallas, TX;
gInova Heart and Vascular Institute, Falls Church, VA;
hDepartment of Infectious Disease, Wake Forest Baptist Health, Winston-Salem, NC; and
iDepartment of Radiology, Cardiovascular Imaging Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA.
Correspondence to: Gerald S. Bloomfield, MD, MPH, Duke University School of Medicine, Duke Clinical Research Institute, 300 West Morgan Street, Durham, NC 27701 (e-mail: [email protected]).
This study is supported through NIH grants U01HL123336, to the Clinical Coordinating Center, and U01HL123339, to the Data Coordinating Center and funding from Kowa Pharmaceuticals America, Inc., Gilead Sciences, Inc., and ViiV Healthcare. NIAID is supporting this study through grants UM1 AI068636, which supports the ACTG Leadership and Operations Center; UM1 AI068634, which supports the ACTG Statistical and Data Management Center; and UM1 AI106701, which supports the ACTG Laboratory Center. P30DK 040561, KOWA Pharmaceuticals, and Gilead Sciences to SKG. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute or the National Institute of Allergy and Infectious Diseases; the National Institutes of Health; or the US Department of Health and Human Services.
G.S.B. has received a grant from NIH/NIMHD R01MD013493 outside the submitted work. HR has received grants from NIH/NHLBI HL123339 and KOWA Pharmaceuticals during the conduct of the study and grants from NIH/NIAID AI068634, NIH/NIAID AI123001, NIH/NHLBI HL137562, and NIH/NHLBI HL146199 outside the submitted work. K.V.F. has received nonfinancial support from American College of Cardiology and International AIDS Society and personal fees from Gilead Sciences, Inc, outside the submitted work. C.J.F. has received grants from Gilead Sciences during the conduct of the study and grants from ViiV healthcare, Janssen, Merck, Cytodyn, Amgen, and Abbvie outside the submitted work. J.P. has received grants for clinical research from Abbott, American Heart Association, Association for the Advancement of Medical Instrumentation, Bayer, Boston Scientific, and Philips and serves as a consultant to Abbott, Abbvie, Ablacon, Altathera, ARCA Biopharma, Biotronik, Boston Scientific, Bristol Myers Squibb, LivaNova, Medtronic, Milestone, ElectroPhysiology Frontiers, Pfizer, Sanofi, Philips, and Up-to-Date. M.V.Z. has received a research grant from Gilead Sciences during the conduct of the study. M.T.L. has received research grants from NHLBI U01 HL123339 and Kowa during the conduct of the study; and from AstraZeneca CT core laboratory for clinical trials outside the submitted work. U.H. has received research grants from KOWA on behalf of the institution during the conduct of the study, personal fees from Duke University, consulting fees from Recor Medical, and grants from KOWA, AstraZeneca, Medimmune, HeartFlow on behalf of MGH outside the submitted work. S.K.G. has received grants from NIH, KOWA, Gilead Sciences, and Viiv during the conduct of the study, personal fees from Theratechnologies Inc, consulting and personal fees from Viiv outside the submitted work. P.S.D. has received grants from KOWA, Gilead Sciences, and Viiv during the conduct of the study. The remaining authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
